Floatz logo

Sleeping Beauty Transposed Pbl

Endocrine/Neuroendocrine

National Cancer Institute (NCI)gene_therapyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

61 Active assets in the Endocrine/Neuroendocrine cohort.

Asset / SponsorPhaseRating
Bms-907351
Fox Chase Cancer Center
Phase 3BB
Irinotecan
First Affiliated Hospital Xi'an Jiaotong University
Phase 4BB
FLUOROURACILUM
ITM Solucin GmbH
Phase 3BB
Eloxatin
ITM Solucin GmbH
Phase 3BB
Pasireotide
RECORDATI GROUP
Phase 4BB

View all 50 →

Same molecule, other indications

Sleeping Beauty Transposed Pbl is also rated in:

Gastrointestinal/Genitourinary CancersDormant
CCC
Indicative ·
53 / 100
View asset →
non-small cell lung carcinomaDormant
CC
Indicative ·
46 / 100
View asset →
breast cancerDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →